Figure 5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Figure 5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>External validation of the b.TRPC model in an independent dataset. <b>A</b> and <b>B,</b> ROC curves assessing the predictive performance of b.TRPC for 0.5-, 1-, and 2-year CRPC-free survival in the external validation cohort. <b>C</b> and <b>D,<...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Ruiliang Wang (17333340) (author)
Altres autors: Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Publicat: 2025
Matèries:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Circulating tumor cells/DNA/exosomes
Genitourinary Cancers
Liquid Biopsy
Prostate Cancer
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars